Cantex is developing azeliragon, a novel antagonist of RAGE (the receptor for advanced glycation endproducts)... Cantex Pharmaceuticals, Inc. is a clinical stage pharmaceutical company developing novel, well tolerated, oral treatments of cancer,..
Relevance: 11.096936